Rugby Cetirizine Hydrochloride And Pseudoephedrine Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 0536-1279

1 FDA label image from Rugby Laboratories · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Rugby Cetirizine Hydrochloride And Pseudoephedrine Hydrochloride (NDC 0536-1279). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rugby Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rugby-cetirizine-hydrochloride-carton-image.jpg (Rugby Cetirizine Hydrochloride Carton Image)

Rugby-cetirizine-hydrochloride-carton-image.jpg (Rugby Cetirizine Hydrochloride Carton Image)
Packaging label for Rugby Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride Extended-Release Tablets, containing 5 mg/120 mg strength per tablet. The label highlights its use as an antihistamine and nasal decongestant for indoor and outdoor allergies, allergy and sinus relief, providing 12-hour symptom relief. The package includes 12 extended-release tablets and shows the Rugby Laboratories logo and NDC 0536-1279-12.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.